Brentwood, Tenn.-based Ardent Health has stopped paying the severance it owed to former President and CEO Marty Bonick and has canceled his unvested stock awards, the company disclosed in a filing with the Securities and Exchange Commission dated Oct. 23. The board of directors determined that Mr. Bonick did not fully disclose compensation he received from third parties.
The Oct. 23 SEC filing is the sole source for these actions and the board’s conclusion as reported in the source. The filing links the company’s decision — withholding severance payments and rescinding unvested equity — directly to the board’s finding about undisclosed outside pay.
According to the reported SEC filing, Ardent’s board concluded that Mr. Bonick failed to fully disclose compensation from third parties. As a result, the company has ceased the severance it previously owed and has canceled his unvested stock awards.
The source did not report several details commonly of interest in matters involving executive departures, including:
Because the source material is limited to the SEC filing disclosure, those details were not reported and therefore cannot be confirmed here.
The board’s decision to withhold severance and cancel unvested equity is a substantive corporate response tied to its finding that an executive did not fully disclose outside compensation. Withholding contractually promised severance or rescinding equity awards are consequential remedies that boards sometimes adopt when they determine an executive breached disclosure obligations or other material policies.
This action affects at least three stakeholders directly named in the filing: the company (Ardent Health), the board of directors that made the determination, and the former executive, Marty Bonick. The decision was recorded in an SEC filing, which is the formal mechanism for publicly traded companies to disclose material events to investors and regulators.
The disclosure referenced in this report appeared in an Oct. 23 filing with the Securities and Exchange Commission. The source identifies Mr. Bonick as the former president and CEO and lists the corporate measures taken following the board’s finding.
Other timeline markers — including Mr. Bonick’s exact date of departure from the company, whether he resigned or was removed, and any subsequent developments after the filing — were not included in the source material and therefore are not reported here.
Board actions that affect an executive’s departure compensation can raise questions for investors, employees, and governance observers. Typical points of interest include the nature and extent of any undisclosed outside compensation, whether company policies or contractual terms were breached, and whether the company will pursue recovery of funds or other remedies.
The source filing does not provide those particulars, so it is not possible from the available report to describe the third-party pay at issue, the board’s investigative process, or any follow-up steps the company plans to take.
The Oct. 23 SEC filing documents the board’s finding and the immediate measures taken by Ardent Health: cessation of severance payments and cancellation of unvested stock awards. The source did not report any further actions, such as legal proceedings, claims for repayment, changes in corporate policy, or subsequent board statements.
Anyone seeking further details will need to consult additional disclosures from Ardent Health, subsequent SEC filings, or official statements from the company or its board. The current report is limited to the facts presented in the Oct. 23 filing: the location of the company (Brentwood, Tenn.), the identity of the former executive (Marty Bonick), the board’s determination regarding undisclosed third-party compensation, and the company’s immediate remedial steps as described above.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.